Drug Development

Sep 10, 2018
By BioPharm International Editors
The collaboration will explore the potential of Dyadic’s gene-expression platform to produce multiple biologic vaccines and drugs.
Sep 01, 2018
BioPharm International
The development and optimization of an efficient conjugation process involves identifying the critical quality attributes and monitoring critical process parameters.
Sep 01, 2018
BioPharm International
Sharing of bioprocessing know-how can help resolve pressing industry problems.
Sep 01, 2018
BioPharm International
Andrew Bulpin, head of Process Solutions, MilliporeSigma, shares insights on characterizing CQAs in biopharmaceutical development and the different tests that should be carried out when assessing an investigational drug.
Aug 29, 2018
By BioPharm International Editors
Protagen Protein Services, a CRO, now offers quicker and more accurate characterization of biomolecular stability using differential scanning calorimetry (DSC).
Aug 24, 2018
By BioPharm International Editors
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
Aug 06, 2018
By BioPharm International Editors
Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.
Aug 06, 2018
By BioPharm International Editors
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.
Aug 01, 2018
BioPharm International
The changing regulatory and manufacturing environment is ushering in a new approach to drug development.
Aug 01, 2018
By BioPharm International Editors
GlaxoSmithKline and 23andMe, a personal genomics and biotechnology company, will partner to research and develop new drugs using human genetics.
native1_300x100
lorem ipsum